SlideShare uma empresa Scribd logo
1 de 18
  Chronische Myeloische Leukämie: Patientensicht und Infoquellen LebensMUT Krebsinformationstag 2011 Grosshadern, 23.07.2011 Jan Geißler, Leukämie-Online e.V. / LeukaNET / CML Advocates Network
CML: Von einer tödlichen zu einer chronischen Erkrankung in nur 15 Jahren ,[object Object],Überlebenswahrscheinlichkeit ,[object Object],[object Object],Jahr nach Diagnose
CML: Ein Löwe, den man  besser im guten Käfig hält
CML-Therapieerfolg ist  abhängig von verschiedenen Faktoren ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Therapietreue: so bedeutend! ,[object Object],CML Adherence (ADAGIO study 2009) Monat nach Therapiebeginn Anteil 100% therapietreuer  Patienten Monat nach Therapiebeginn Anteil der Patienten in guter molekularer Remission Long Term Adherence to  Imatinib, Alex Bazeos et al, ASH 2009 Therapietreue >90% Therapietreue <90% ,[object Object]
Gute Patienteninformation kann  Leben und Überleben verbessern ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Patientengruppen sind  Navigatoren für Patienten ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Leukämie- Online ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Homepage- Artikel: Neuigkeiten aus Forschung und Politik ,[object Object],[object Object],[object Object]
Sehr aktive Diskussionsforen ,[object Object]
Diskussionsforen:  Email-Benachrichtigung
SMS-Erinnerungsdienst ,[object Object],[object Object],[object Object]
Hilfreiche Dokumente: DLH-Ratgeber ,[object Object],[object Object]
Hilfreiche Dokumente: CML-Therapieleitlinien ,[object Object]
Informationen über Arzneimittel ,[object Object]
Hilfreiche Dokumente: Umgang mit Nebenwirkungen ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais de patvocates

Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...patvocates
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
 
iCMLf Forum at ASH: Introductory Presentation
iCMLf Forum at ASH: Introductory PresentationiCMLf Forum at ASH: Introductory Presentation
iCMLf Forum at ASH: Introductory Presentationpatvocates
 
Richard Sullivan - eCancerHub
Richard Sullivan - eCancerHubRichard Sullivan - eCancerHub
Richard Sullivan - eCancerHubpatvocates
 
Gilles Frydman - ACOR - EMCC2011
Gilles Frydman - ACOR - EMCC2011Gilles Frydman - ACOR - EMCC2011
Gilles Frydman - ACOR - EMCC2011patvocates
 
Costello - EMCC Cancer on the Internet
Costello - EMCC Cancer on the Internet Costello - EMCC Cancer on the Internet
Costello - EMCC Cancer on the Internet patvocates
 
Costello - Morning Tutorial on Social Media - RARE CONNECT
Costello - Morning Tutorial on Social Media - RARE CONNECTCostello - Morning Tutorial on Social Media - RARE CONNECT
Costello - Morning Tutorial on Social Media - RARE CONNECTpatvocates
 
Introduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social MediaIntroduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social Mediapatvocates
 
Introduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social MediaIntroduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social Mediapatvocates
 
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011Dr Peschel LebensMUT Krebsinformationstag 23.07.2011
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011patvocates
 
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011patvocates
 

Mais de patvocates (11)

Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
iCMLf Forum at ASH: Introductory Presentation
iCMLf Forum at ASH: Introductory PresentationiCMLf Forum at ASH: Introductory Presentation
iCMLf Forum at ASH: Introductory Presentation
 
Richard Sullivan - eCancerHub
Richard Sullivan - eCancerHubRichard Sullivan - eCancerHub
Richard Sullivan - eCancerHub
 
Gilles Frydman - ACOR - EMCC2011
Gilles Frydman - ACOR - EMCC2011Gilles Frydman - ACOR - EMCC2011
Gilles Frydman - ACOR - EMCC2011
 
Costello - EMCC Cancer on the Internet
Costello - EMCC Cancer on the Internet Costello - EMCC Cancer on the Internet
Costello - EMCC Cancer on the Internet
 
Costello - Morning Tutorial on Social Media - RARE CONNECT
Costello - Morning Tutorial on Social Media - RARE CONNECTCostello - Morning Tutorial on Social Media - RARE CONNECT
Costello - Morning Tutorial on Social Media - RARE CONNECT
 
Introduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social MediaIntroduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social Media
 
Introduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social MediaIntroduction - Teaching Lecture on Social Media
Introduction - Teaching Lecture on Social Media
 
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011Dr Peschel LebensMUT Krebsinformationstag 23.07.2011
Dr Peschel LebensMUT Krebsinformationstag 23.07.2011
 
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011
Von Bubnoff - LebensMUT Krebsinformationstag, 23 Juli 2011
 

Geissler - LebensMUT Krebsinformationstag, 23 Juli 2011

  • 1. Chronische Myeloische Leukämie: Patientensicht und Infoquellen LebensMUT Krebsinformationstag 2011 Grosshadern, 23.07.2011 Jan Geißler, Leukämie-Online e.V. / LeukaNET / CML Advocates Network
  • 2.
  • 3. CML: Ein Löwe, den man besser im guten Käfig hält
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.